Hovid Berhad operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hovid Berhad with three other
pharmaceutical manufacturers in Asia:
Aprogen Pharmaceuticals Inc
of South Korea
sales of 46.10 billion Korean Won [US$41.54 million]
Kotra Industries Bhd
(166.37 million Malaysian Ringgits [US$41.53 million]
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd
based in China
(269.59 million Chinese Renmimbi [US$41.64 million]
of which 98%
was Chinese Herbal Medicine Trade).
Hovid Berhad reported sales of 169.94 million Malaysian Ringgits (US$42.42 million)
June of 2017.
decrease of 10.1%
versus 2016, when the company's sales were 189.03 million Malaysian Ringgits.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Hovid Berhad had sales
of 164.81 million Malaysian Ringgits.